Ischemic stroke is one of the leading causes of death and disability worldwide. There is no
effective treatment for ischemic stroke apart from thrombolytic therapy, which has a narrow …

Exogenous stem cell therapy (SCT) has been recognized recently as a promising
neuroregenerative strategy to augment recovery in stroke survivors. Mesenchymal stem …

Cerebrovascular accidents, also known as strokes, are the leading cause of permanent
disability in society, presenting significant socioeconomic and healthcare costs. They can be …

Cell therapy with mesenchymal stromal cells (MSCs) was found to protect neurons from
damage after experimental stroke and is currently under investigation in clinical stroke trials …

Intravenous administration of mesenchymal stem cells (IV-MSC) protects the ischemic rat
brain in a stroke model, but the molecular mechanism underlying its therapeutic effect is …

Introduction: Stroke is a major cause of mortality and disability with a narrow therapeutic
window. Stem cell therapy may enhance the stroke recovery. Areas Covered: Regenerative …

Cell transplantation is a promising treatment strategy for many neurological disorders,
including stroke, which can target multiple therapeutic mechanisms in a sustained fashion …

Mesenchymal stem cells (MSCs) are promising seed cells for neural regeneration therapy
owing to their plasticity and accessibility. They possess several inherent characteristics …

Ischemic stroke represents a major, worldwide health burden with increasing incidence.
Patients affected by ischemic strokes currently have few clinically approved treatment …

Ischemic stroke (IS) is a serious cerebrovascular disease with high morbidity and disability
worldwide. Despite the great efforts that have been made, the prognosis of patients with IS …